Monalizumab data from COAST trial presented at ESMO Congress 2021
Innate Pharma Reports First Half 2021 Financial Results and Business Update
Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update
Monalizumab and ANKET™ Data will be Presented at ESMO 2021 Virtual Congress
Innate Pharma to Participate in Upcoming Investor Conferences
Number of Shares and Voting Rights of Innate Pharma as of August 1, 2021
Number of Shares and Voting Rights of Innate Pharma as of July 1, 2021
Update on Avdoralimab Phase 2 FORCE Trial in COVID-19 Patients with Severe Pneumonia
Innate Pharma Presents Preliminary Data from TELLOMAK Trial Showing Clinical Response for Lacutamab in Mycosis Fungoides
Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company Strategy
